Pulmonx (LUNG) Common Equity (2019 - 2025)
Pulmonx (LUNG) posted quarterly Common Equity of $54.1 million for Q4 2025, down 36.93% year-over-year from $85.8 million in Q4 2024, and down 9.86% quarter-over-quarter from $60.0 million in Q3 2025.
Pulmonx (LUNG) Common Equity (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Common Equity for 7 consecutive years, with $54.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity fell 36.93% year-over-year to $54.1 million; the TTM figure through Dec 2025 stood at $54.1 million (down 36.93% YoY), while the FY2025 annual figure was $54.1 million, down 36.93% from the prior year.
- Common Equity slipped to $54.1 million in Q4 2025 per LUNG's latest filing, from $60.0 million in the prior quarter.
- Across five years, Common Equity topped out at $216.1 million in Q1 2021 and bottomed at $54.1 million in Q4 2025.
- Historically, Common Equity has averaged $133.4 million across 5 years, with a median of $129.8 million in 2023.
- Annual changes were most pronounced in 2021 — Common Equity surged 211.39% — and 2025, when it sank 36.93%.
- Pulmonx's Common Equity stood at $193.2 million in 2021, then slipped by 20.3% to $154.0 million in 2022, then declined by 23.18% to $118.3 million in 2023, then dropped by 27.47% to $85.8 million in 2024, then plunged by 36.93% to $54.1 million in 2025.
- Business Quant data shows LUNG's Common Equity at $54.1 million in Q4 2025, $60.0 million in Q3 2025, and $69.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Pulmonx | 97.63 Mn | 27.88 Mn | - | 54.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.12 Mn |
| Sep 30, 2025 | 60.03 Mn |
| Jun 30, 2025 | 69.09 Mn |
| Mar 31, 2025 | 77.67 Mn |
| Dec 31, 2024 | 85.81 Mn |
| Sep 30, 2024 | 93.93 Mn |
| Jun 30, 2024 | 101.18 Mn |
| Mar 31, 2024 | 110.50 Mn |
| Dec 31, 2023 | 118.32 Mn |
| Sep 30, 2023 | 125.74 Mn |
| Jun 30, 2023 | 133.95 Mn |
| Mar 31, 2023 | 143.93 Mn |
| Dec 31, 2022 | 154.01 Mn |
| Sep 30, 2022 | 163.48 Mn |
| Jun 30, 2022 | 172.18 Mn |
| Mar 31, 2022 | 182.15 Mn |
| Dec 31, 2021 | 193.24 Mn |
| Sep 30, 2021 | 202.83 Mn |
| Jun 30, 2021 | 208.87 Mn |
| Mar 31, 2021 | 216.15 Mn |